ABP-500

N/A

Report date: 2023/01/07 17:15:51

Base Information

Drug NameABP-500

Drug Alias NameABP-500

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAnti-Cluster of differentiation 47Tumor necrosis factor ligand superfamily member 12 inhibitors

TargetsCluster of differentiation 47Tumor necrosis factor ligand superfamily member 12

Therapy Area/IndicationsSolid tumoursHematologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesAbpro Corp

China Registration ClassN/A

Develop Information

Active CompaniesAbpro Corp

Inactive CompaniesN/A

Active IndicationsSolid tumoursHematologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A